Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short
Zepbound and Mounjaro have now underperformed expectations for two straight quarters.
since
auto-detected in 350 stories
86 days ago
3 months ago
found
a story from The Daily Mail › The Daily Mail
4 months ago
|← first ← previous page 4 of 4